Editorial
Copyright ©The Author(s) 2016.
World J Radiol. Nov 28, 2016; 8(11): 851-856
Published online Nov 28, 2016. doi: 10.4329/wjr.v8.i11.851
Table 1 Results of PubMed query for clinical studies comparing 11C-choline, fluorocholine, or 11C-acetate over fluorodeoxy-D-glucose in 15 or more patients
DiseaseClinical roleFirst authorPublish yearNo. of patientsTracer(s) compared to FDGPrimary results
Prostate cancerDiagnosisLiu2016Meta-analysis 56 trials 3586 patients11C-choline 18F-choline, 11C-acetate18F-choline AUC 0.94, 95%CI: 0.92-0.96; 11C-choline AUC 0.89, 95%CI: 0.86-0.91; 11C-acetate AUC 0.78, 95%CI: 0.74-0.81; FDG AUC 0.73, 95%CI: 0.69-0.77
DetectionWata-nabe20104311C-cholineSensitivity 73%, 88%, and 31% for 11C-choline, MRI, and FDG, respectively
Re-stagingRichter20107311C-cholineSensitivity was 60.6% for 11C-choline and 31% for FDG
Hepato-cellular carciomaDetection, metastaticHo200712111C-acetatePatient-based sensitivity for metastasis was 64% and 79% for 11C-cetate and FDG, respectively
Detection, primaryHo20035711C-acetateSensitivity was 87% and 47% for 11C-acetate and FDG respectively
Detection, primary/metastaticPark200811211C-acetateSensitivity was 75%, 61%, and 83% for 11C-acetate, FDG, and dual-tracer PET.CT, respectively
Detection, primaryLarsson20124411C-acetateDetection rate was 34/44 for 11C-acetate and 13/44 for FDG (P < 0.001)
Detection, primaryTalbot20108118F-cholineSensitivity was 88% for 18F-choline vs 68% for FDG
DetectionWu20117611C-choline11C-choline PET was positive in 28 patients with negative FDG PET
DiagnosisCastilla-Lievre20162811C-cholineSensitivity was 75%, 36%, and 93% for 11C-holine, FDG, and dual tracers, respectively
Malignant gliomaDiagnosisYama-moto20081511C-acetate, 11C-methi-onineSensitivity was 90%, 100%, and 40% for 11C-acetate, 11C-methionine, and FDG, respectively
Re-stagingTan20115511C-cholineSensitivity/specificity was 92%/88%, 87%/81%, and 77%/63% for 11C-choline, MRI, and FDG, respectively
Nasopha-ryngeal cancerStagingWu20111511C-cholineSensitivity for detecting locally advanced nasopharyngeal cancer was 100% vs 86% percent for 11C-choline and FDG, respectively
Multiple myelomaStagingLin20141511C-acetateDiffuse infiltration was detected in 100% of patients with 11C-acetate vs 40% with FDG
Re-stagingCassou-Mounat20162118F-choline18F-fluorocholine detected 75% more lesions, and with higher intra-observer agreement than FDG (kappa score 0.89 vs 0.81)
Renal cell carcinomaDiagnosisOyama20142911C-acetateDetection rate was 72% for 11C-acetate vs 22% for FDG